1. Louis DN, Ohgaki H, Wiestler OD et al, eds. WHO Classification of Tumours of the Central Nervous System. Lyon: IARC, 2016.;
2. Furnari FB, Fenton T, Bachoo RM et al. Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 2007; 21: 2683-710. https://doi.org/10.1101/gad.1596707;
3. Zhang M, Ye G, Li J et al. Recent advance in molecular angiogenesis in glioblastoma: the challenge and hope for anti-angiogenic therapy. Brain Tumor Pathol 2015; 32: 229-36. https://doi.org/10.1007/s10014-015-0233-5;
4. Stupp R, Mason WP, van den Bent MJ et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352: 987-96. https://doi.org/10.1056/NEJMoa043330;
5. Touat M, Idbaih A, Sanson M et al. Glioblastoma targeted therapy: updated approaches from recent biological insights. Ann Oncol 2017; 28: 1457-72. https://doi.org/10.1093/annonc/mdx106;